InvestorsHub Logo

BlackDoggie

11/10/17 10:12 AM

#18092 RE: BlueHorseshoe13 #18091

I think it's important to remember that the data was still blinded - even the FDA couldn't see the data on 10/12. This line of reasoning is off base at face value.

Now, why the FDA required additional patients is still an interesting question. I have a completely unsubstantiated theory based on the rejected ODD application, but it has nothing to do with data.

misiu143

11/10/17 1:42 PM

#18103 RE: BlueHorseshoe13 #18091

BlueHorsehoe13- This is a VERY good point...